Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, filed on May 6, 2015, reports on events occurring on May 4 and May 5, 2015. Acadia Healthcare Company, Inc. (Acadia) entered into a material definitive agreement to conduct a public offering of its common stock.
Key Financial Metrics and Transaction Details
- Offering Size: 4,500,000 shares of Common Stock (Firm Shares).
- Offering Price: $66.50 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 675,000 shares.
- Net Proceeds: Approximately $287.7 million (after underwriting discounts and commissions, excluding the option).
- Use of Proceeds: Repayment of outstanding indebtedness on the senior secured revolving line of credit, funding acquisition activity, and general corporate purposes.
- Closing Date: Scheduled for or about May 11, 2015.
Material Changes and Agreements
The primary material change is the entry into an Underwriting Agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated and Jefferies LLC. This agreement facilitates the equity raise described above. Additionally, significant shareholders, including Waud Capital Partners, L.L.C., affiliates of Bain Capital Partners, LLC, and the Company's directors and executive officers, have entered into 60-day "lock-up" agreements restricting the sale of their shares.
Outlook, Risks, and Contingencies
The filing indicates the Company intends to strengthen its balance sheet by repaying debt with the net proceeds. The Underwriting Agreement includes customary representations, warranties, and indemnification provisions for the Underwriters. The text notes that affiliates of certain Underwriters are lenders under the Company's existing senior credit facility, representing a potential conflict of interest or related party transaction context.
Key Facts for Investor Verification
- Verify the final closing date and whether the 675,000 share over-allotment option was exercised.
- Confirm the specific amount of debt repaid from the $287.7 million in net proceeds.
- Review the full Underwriting Agreement (Exhibit 1) for specific covenants and indemnification limits.
- Monitor the 60-day lock-up expiration date for potential selling pressure from insiders and major investors.